Selected research
Industry Research
Flu Shots Industry Research Report 2026
Market perspective
The global Flu Shots market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Flu Shots is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Flu Shots is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Flu Shots market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Flu Shots Market by Company
SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type
Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application
Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flu Shots by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flu Shots in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Influenza Whole Virus Vaccines
- Influenza Virus Subunit Vaccines
- Influenza Virus Split Vaccines
Applications
- Avian Influenza Virus-A
- Avian Influenza Virus-B
Companies covered
- SANOFI
- GSK
- VAXTEC
- TIANYUAN BIO-PHARMA
- SIOBP
- SINOVAC
- LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
- HUALAN BIO
- CHANGSHENG
- CCBIO
- ALEPH BIOMEDICAL
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Flu Shots Market Size (2021-2032)
- 2.2.2 Global Flu Shots Sales (2021-2032)
- 2.2.3 Global Flu Shots Market Average Price (2021-2032)
- 2.3 Flu Shots by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Influenza Whole Virus Vaccines
- 2.3.3 Influenza Virus Subunit Vaccines
- 2.3.4 Influenza Virus Split Vaccines
- 2.4 Flu Shots by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Avian Influenza Virus-A
- 2.4.3 Avian Influenza Virus-B
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Flu Shots Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Flu Shots Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Flu Shots Revenue of Manufacturers (2021-2026)
- 3.4 Global Flu Shots Average Price by Manufacturers (2021-2026)
- 3.5 Global Flu Shots Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Flu Shots, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Flu Shots, Product Type & Application
- 3.8 Global Manufacturers of Flu Shots, Established Date
- 3.9 Global Flu Shots Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 SANOFI
- 4.1.1 SANOFI Company Information
- 4.1.2 SANOFI Business Overview
- 4.1.3 SANOFI Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 SANOFI Flu Shots Product Portfolio
- 4.1.5 SANOFI Recent Developments
- 4.2 GSK
- 4.2.1 GSK Company Information
- 4.2.2 GSK Business Overview
- 4.2.3 GSK Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GSK Flu Shots Product Portfolio
- 4.2.5 GSK Recent Developments
- 4.3 VAXTEC
- 4.3.1 VAXTEC Company Information
- 4.3.2 VAXTEC Business Overview
- 4.3.3 VAXTEC Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 VAXTEC Flu Shots Product Portfolio
- 4.3.5 VAXTEC Recent Developments
- 4.4 TIANYUAN BIO-PHARMA
- 4.4.1 TIANYUAN BIO-PHARMA Company Information
- 4.4.2 TIANYUAN BIO-PHARMA Business Overview
- 4.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
- 4.4.5 TIANYUAN BIO-PHARMA Recent Developments
- 4.5 SIOBP
- 4.5.1 SIOBP Company Information
- 4.5.2 SIOBP Business Overview
- 4.5.3 SIOBP Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 SIOBP Flu Shots Product Portfolio
- 4.5.5 SIOBP Recent Developments
- 4.6 SINOVAC
- 4.6.1 SINOVAC Company Information
- 4.6.2 SINOVAC Business Overview
- 4.6.3 SINOVAC Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SINOVAC Flu Shots Product Portfolio
- 4.6.5 SINOVAC Recent Developments
- 4.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
- 4.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information
- 4.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
- 4.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
- 4.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
- 4.8 HUALAN BIO
- 4.8.1 HUALAN BIO Company Information
- 4.8.2 HUALAN BIO Business Overview
- 4.8.3 HUALAN BIO Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 HUALAN BIO Flu Shots Product Portfolio
- 4.8.5 HUALAN BIO Recent Developments
- 4.9 CHANGSHENG
- 4.9.1 CHANGSHENG Company Information
- 4.9.2 CHANGSHENG Business Overview
- 4.9.3 CHANGSHENG Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 CHANGSHENG Flu Shots Product Portfolio
- 4.9.5 CHANGSHENG Recent Developments
- 4.10 CCBIO
- 4.10.1 CCBIO Company Information
- 4.10.2 CCBIO Business Overview
- 4.10.3 CCBIO Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CCBIO Flu Shots Product Portfolio
- 4.10.5 CCBIO Recent Developments
- 4.11 ALEPH BIOMEDICAL
- 4.11.1 ALEPH BIOMEDICAL Company Information
- 4.11.2 ALEPH BIOMEDICAL Business Overview
- 4.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
- 4.11.5 ALEPH BIOMEDICAL Recent Developments
5 Global Flu Shots Market Scenario by Region
- 5.1 Global Flu Shots Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Flu Shots Sales by Region: 2021-2032
- 5.2.1 Global Flu Shots Sales by Region: 2021-2026
- 5.2.2 Global Flu Shots Sales by Region: 2027-2032
- 5.3 Global Flu Shots Revenue by Region: 2021-2032
- 5.3.1 Global Flu Shots Revenue by Region: 2021-2026
- 5.3.2 Global Flu Shots Revenue by Region: 2027-2032
- 5.4 North America Flu Shots Market Facts & Figures by Country
- 5.4.1 North America Flu Shots Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Flu Shots Sales by Country (2021-2032)
- 5.4.3 North America Flu Shots Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Flu Shots Market Facts & Figures by Country
- 5.5.1 Europe Flu Shots Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Flu Shots Sales by Country (2021-2032)
- 5.5.3 Europe Flu Shots Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Flu Shots Market Facts & Figures by Country
- 5.6.1 Asia Pacific Flu Shots Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Flu Shots Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Flu Shots Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Flu Shots Market Facts & Figures by Country
- 5.7.1 South America Flu Shots Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Flu Shots Sales by Country (2021-2032)
- 5.7.3 South America Flu Shots Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Flu Shots Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Flu Shots Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Flu Shots Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Flu Shots Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Flu Shots Sales by Type (2021-2032)
- 6.1.1 Global Flu Shots Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Flu Shots Sales Market Share by Type (2021-2032)
- 6.2 Global Flu Shots Revenue by Type (2021-2032)
- 6.2.1 Global Flu Shots Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Flu Shots Revenue Market Share by Type (2021-2032)
- 6.3 Global Flu Shots Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Flu Shots Sales by Application (2021-2032)
- 7.1.1 Global Flu Shots Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Flu Shots Sales Market Share by Application (2021-2032)
- 7.2 Global Flu Shots Revenue by Application (2021-2032)
- 7.2.1 Global Flu Shots Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Flu Shots Revenue Market Share by Application (2021-2032)
- 7.3 Global Flu Shots Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Flu Shots Value Chain Analysis
- 8.1.1 Flu Shots Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Flu Shots Production Mode & Process
- 8.2 Flu Shots Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Flu Shots Distributors
- 8.2.3 Flu Shots Customers
9 Global Flu Shots Analyzing Market Dynamics
- 9.1 Flu Shots Industry Trends
- 9.2 Flu Shots Industry Drivers
- 9.3 Flu Shots Industry Opportunities and Challenges
- 9.4 Flu Shots Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst